INVENTIONMED S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2185 PLN | -0.23% |
|
-8.00% | -14.65% |
| 15/05 | InventionMed S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 14/02 | InventionMed S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Sales 2022 | 0 0.02 0.34 | Sales 2023 | 0 0 0.05 | Capitalization | 5.19Cr 21Cr 433.08Cr |
|---|---|---|---|---|---|
| Net income 2022 | -2.2Cr -8.82Cr -183.53Cr | Net income 2023 | -10L -40.11L -8.34Cr | EV / Sales 2022 | 6,43,05,65,560 x |
| Net cash position 2022 | 16.42L 65.84L 14Cr | Net Debt 2023 | 32.45L 1.3Cr 27Cr | EV / Sales 2023 | 91,17,19,17,355 x |
| P/E ratio 2022 |
-1.25
x | P/E ratio 2023 |
-27.5
x | Employees | 4 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.1% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.23% | ||
| 1 week | -8.00% | ||
| Current month | -7.81% | ||
| 1 month | -3.74% | ||
| 3 months | -2.89% | ||
| 6 months | -15.31% | ||
| Current year | -14.65% |
1 week
0.21
0.23
1 month
0.210.25
Current year
0.200.32
1 year
0.160.32
3 years
0.110.42
5 years
0.110.74
10 years
0.085.70
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/18/29 | |
Maciej Zegarski
COO | Chief Operating Officer | - | - |
Andrzej Szurek
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lidia Rudnicka
BRD | Director/Board Member | - | 29/18/29 |
Cezary Jasinski
PRN | Corporate Officer/Principal | - | - |
| Director/Board Member | 42 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/24/25 | 0.2185 | -0.23% | 58,156 |
| 24/24/24 | 0.219 | +3.30% | 289,611 |
| 21/24/21 | 0.212 | -6.19% | 222,626 |
| 20/24/20 | 0.226 | +1.80% | 161,029 |
| 19/24/19 | 0.222 | -6.53% | 357,081 |
End-of-day quote Warsaw S.E., June 25, 2024
More quotes
Inventionmed SA, formerly known as Athos Venture Capital SA, is a Poland-based medical technology company. The Company is focused on developing TutorDerm, an advanced medical simulator based on virtual reality (VR) technology for the purpose of training doctors, medical students and cosmetologists in conducting dermatological procedures.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.65% | 1.1Cr | |
| -3.30% | 3.01TCr | |
| +43.43% | 991.29Cr | |
| +36.91% | 452.02Cr | |
| -36.88% | 239.1Cr | |
| -8.48% | 162.08Cr | |
| -29.26% | 122.25Cr | |
| +6.61% | 95Cr | |
| -45.05% | 94Cr | |
| -46.72% | 73Cr |
- Stock Market
- Equities
- INM Stock
